Acadia Pharmaceuticals Inc. ACAD
20.57 USD +0.10 (+0.49%)
At closeNov 3, 2026, 4:32 PM EST
20.57 0.00 0.00%
After hours · Nov 3, 4:32 PM ET
20.45 Day range 20.81
18.39 52-week range 30.96
- YTD
- -22.99%
- 1 year
- -8.05%
Analyst view
Consensus: buy
Buy
Price target (mean) 30.53 +48.4% upside
Now 20.57
- Target (low)
- 16.00
- Target (mean)
- 30.53
- Target (high)
- 37.00
Ratings (0m) 20 14 buy · 5 hold · 1 sell
- Strong buy4
- Buy10
- Hold5
- Sell1
- Strong sell0
Recommendation trend
- This month 20
- 1 month ago 20
- 2 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.1825 | 0.11 – 0.29 | 0.42 | -56.5% | 332.55M | +19.4% | 14 |
| Next quarter | 0.20967 | 0.14 – 0.25 | 0.1375 | +52.5% | 361.57M | +27.3% | 13 |
| Current year | 0.59504 | 0.50 – 0.70 | 0.8298 | -28.3% | 1.27B | +18.7% | 14 |
| Next year | 0.92072 | 0.22 – 1.87 | 0.59504 | +54.7% | 1.43B | +12.4% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Needham | Reiterated | Buy | Buy |
| Oct 13, 2026 | UBS | Downgrade | Buy | Neutral |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 25, 2026 | Deutsche Bank | Maintained | Buy | Buy |
| Sep 25, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 25, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Sep 25, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Sep 25, 2026 | Needham | Maintained | Buy | Buy |
| Sep 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 24, 2026 | Needham | Reiterated | Buy | Buy |
| Aug 25, 2026 | Deutsche Bank | Maintained | Buy | Buy |
| Aug 25, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 25, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 17, 2026 | UBS | Maintained | Buy | Buy |
| Aug 12, 2026 | Needham | Maintained | Buy | Buy |
| Aug 10, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | Oppenheimer | Maintained | Perform | Perform |
| Aug 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 21, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 21, 2026 | Stifel | Maintained | Hold | Hold |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 30, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jun 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Jun 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 8, 2026 | Citigroup | Maintained | Buy | Buy |
| May 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 25, 2026 | B of A Securities | Upgrade | Neutral | Buy |
| Mar 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 27, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
